Rezafungin Acetate Patent Expiration

Rezafungin Acetate is Used for treating candidemia and invasive candidiasis. It was first introduced by Cidara Therapeutics Inc in its drug Rezzayo on Mar 22, 2023.


Rezafungin Acetate Patents

Given below is the list of patents protecting Rezafungin Acetate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Rezzayo US10702573 Dosing regimens for echinocandin class compounds Mar 14, 2033 Cidara Theraps
Rezzayo US11197909 Compositions and methods for the treatment of fungal infections Jul 14, 2038 Cidara Theraps
Rezzayo US11654196 Dosing regimens for echinocandin class compounds Mar 02, 2032 Cidara Theraps
Rezzayo US11712459 Dosing regimens for treatment of fungal infections Mar 15, 2037 Cidara Theraps
Rezzayo US11819533 Compositions and methods for the treatment of fungal infections Jul 11, 2038 Cidara Theraps
Rezzayo US8722619 Antifungal agents and uses thereof Mar 02, 2032 Cidara Theraps
Rezzayo US9526835 Dosing regimens for echinocandin class compounds Mar 14, 2033 Cidara Theraps


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳